Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
about
Herpes zoster: diagnostic, therapeutic, and preventive approaches.Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system.Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled studyTrends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda.Herpes Zoster as a Predictor of HIV Infection in Taiwan: A Population-Based Study.Pathogenesis and current approaches to control of varicella-zoster virus infections.Primary care of women aging with HIV.Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.Live attenuated herpes zoster vaccine for HIV-infected adults.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.[Diagnostics and management of herpes zoster ophthalmicus].A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Immunization of HIV-infected adult patients - French recommendations.Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review.Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.Herpes Zoster in the Older Adult.European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis.Low Rates of Vaccination for Herpes Zoster in Older People Living with HIV.
P2860
Q34376752-B8E436BF-8A71-4B6F-AB74-7E53B03614F0Q34389074-50A12D25-81D4-4EAF-ABBB-FB1FCD01BA65Q34446365-C2E1A911-5A18-4C71-A97C-4C18FE49B5E9Q35534405-9BD9053B-3529-4831-B308-4592CCE20685Q35831661-21E23022-D997-427B-B7FF-B82727BE05AAQ37263293-ECD5FB79-C4D1-4D17-A4DF-E124A3627662Q37272968-B1C236A1-98C0-4E7E-834A-30264CC0B4E6Q37297444-C0462014-F26B-4ADF-92C4-D36098D3DCD9Q38575356-7E36A63F-75BD-4080-B567-237A887DC616Q38638518-CAF09381-1E24-46AD-A229-CFD40129985EQ40058091-53F84DE3-1271-4571-B9C3-5A6DA4C277BAQ40234780-E965C955-40B2-499B-BB41-1B3D3AC3E208Q40560650-466E8125-2FCF-46BB-BE68-EADB6F034D9BQ40615516-7C6F17CC-CBF1-493D-B4D5-6016FD36BC15Q41533836-42CD8912-2B41-49A7-BB6D-38C234DEA9B8Q45324857-F36461E1-EBAC-404E-8950-ABAD76D9E6CFQ47556446-FCBF58D2-8AA2-4C38-B35F-C85DBDCF3021Q47597541-BE9DE3AE-343B-48C9-A835-9C80C368C718Q48003339-89652EA8-CBAD-4912-B303-302D830F4AA2Q53821841-44C729E1-2BA7-426D-A30B-863C63AAF3F2
P2860
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
@en
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
@nl
type
label
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
@en
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
@nl
prefLabel
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
@en
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
@nl
P2860
P356
P1476
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
@en
P2093
Abeer Moanna
David Rimland
P2860
P304
P356
10.1093/CID/CIT165
P407
P577
2013-03-13T00:00:00Z